GSK plc DRC (GSK)

NYSE
Currency in USD
Disclaimer
36.26
-0.07(-0.21%)
Real-time Data
Day's Range
36.2236.42
52 wk Range
33.2038.32
Prev. Close
36.33
Open
36.34
Day's Range
36.22-36.42
52 wk Range
33.2-38.32
Volume
1,117,243
Average Volume (3m)
3,586,277
1-Year Change
3.33%
Shares Outstanding
4,076,145,236
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
41.70
Upside +15.00%

People Also Watch

336.96
ACN
+0.34%
23.73
MRO
-2.75%
97.22
NVS
+0.26%
208.67
NXPI
+1.38%
How do you feel today about GSK?
Vote to see community's results!
or

GSK plc DRC Company Profile

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Employees
69400